The potential of amino acid PET imaging for prediction and monitoring of vorasidenib response in IDH -mutant gliomas
Neuro-Oncology · 2024
DOI: 10.1093/neuonc/noad240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2024. Verfasst von Nathalie L Albert und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, LMU Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Pyridines. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, LMU Hospital, LMU Munich, Munich, Germany.
- Research Center for Medical Image Analysis and Artificial Intelligence (MIAAI), Faculty of Medicine and Dentistry, Danube Private University, Krems, Austria.
- The Brain Tumour Center at the Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
- Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Nathalie L Albert, Matthias Preusser
Zitieren
APA
Albert, N. L., Furtner, J., van den Bent, M. J., & Preusser, M. (2024). The potential of amino acid PET imaging for prediction and monitoring of vorasidenib response in IDH -mutant gliomas. Neuro-Oncology. https://doi.org/10.1093/neuonc/noad240
Vancouver
Albert NL, Furtner J, van den Bent MJ, Preusser M. The potential of amino acid PET imaging for prediction and monitoring of vorasidenib response in IDH -mutant gliomas. Neuro-Oncology. 2024. doi:10.1093/neuonc/noad240
BibTeX
@article{Albert2024,
author = {Albert, Nathalie L and Furtner, Julia and van den Bent, Martin J and Preusser, Matthias},
title = {The potential of amino acid PET imaging for prediction and monitoring of vorasidenib response in IDH -mutant gliomas},
journal = {Neuro-Oncology},
year = {2024},
doi = {10.1093/neuonc/noad240}
}
EUVIMED